{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:56:37Z","timestamp":1780318597340,"version":"3.54.1"},"reference-count":164,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Neurology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/s1474-4422(07)70327-7","type":"journal-article","created":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T17:49:24Z","timestamp":1202752164000},"page":"97-109","source":"Crossref","is-referenced-by-count":731,"title":["Mitochondria in the aetiology and pathogenesis of Parkinson's disease"],"prefix":"10.1016","volume":"7","author":[{"given":"Anthony HV","family":"Schapira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S1474-4422(07)70327-7_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service","volume":"125","author":"Hughes","year":"2002","journal-title":"Brain"},{"issue":"suppl 3","key":"10.1016\/S1474-4422(07)70327-7_bib3","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/ana.10487","article-title":"Genetic and environmental factors in the cause of Parkinson's disease","volume":"53","author":"Warner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0005-2728(98)00164-9","article-title":"Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia","volume":"1410","author":"Schapira","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S1474-4422(07)70327-7_bib5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"1","author":"Schapira","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death","volume":"87","author":"Kroemer","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/S1474-4422(07)70327-7_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(89)90291-2","article-title":"Mitochondrial function in Parkinson's disease","volume":"2","author":"Bindoff","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib9","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","article-title":"Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease","volume":"163","author":"Mizuno","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S1474-4422(07)70327-7_bib10","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease","volume":"55","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.410360612","article-title":"Complex I, iron, and ferritin in Parkinson's disease substantia nigra","volume":"36","author":"Mann","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0304-3940(94)90372-7","article-title":"Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease","volume":"169","author":"Janetzky","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/S1474-4422(07)70327-7_bib13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.410320612","article-title":"Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group","volume":"32","author":"Krige","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410370604","article-title":"Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson's disease","volume":"37","author":"Haas","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/115.2.333","article-title":"Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease","volume":"115","author":"Mann","year":"1992","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(07)70327-7_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-510X(94)90245-3","article-title":"A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease","volume":"125","author":"Taylor","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/S1474-4422(07)70327-7_bib17","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1212\/WNL.45.11.2097","article-title":"Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle","volume":"45","author":"Penn","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(07)70327-7_bib18","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","article-title":"Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled","volume":"26","author":"Keeney","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/S1474-4422(07)70327-7_bib19","doi-asserted-by":"crossref","first-page":"19126","DOI":"10.1073\/pnas.0508215102","article-title":"Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage","volume":"102","author":"Perier","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0006-291X(90)90497-B","article-title":"Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence","volume":"170","author":"Ikebe","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S1474-4422(07)70327-7_bib21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mds.870050406","article-title":"Mitochondrial DNA analysis in Parkinson's disease","volume":"5","author":"Schapira","year":"1990","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(07)70327-7_bib22","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/j.1471-4159.1991.tb02087.x","article-title":"Mitochondrial DNA in postmortem brain from patients with Parkinson's disease","volume":"56","author":"Lestienne","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ng1778","article-title":"Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons","volume":"38","author":"Kraytsberg","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib25","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0006-291X(05)80276-1","article-title":"Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease","volume":"176","author":"Ozawa","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S1474-4422(07)70327-7_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0169-328X(94)00209-W","article-title":"Point mutations of mitochondrial genome in Parkinson's disease","volume":"28","author":"Ikebe","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/S1474-4422(07)70327-7_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/geno.1993.1299","article-title":"Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients","volume":"17","author":"Shoffner","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/S1474-4422(07)70327-7_bib28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1006\/bbrc.1995.1868","article-title":"Absence of the mitochondrial A7237T mutation in Parkinson's disease","volume":"211","author":"Lucking","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S1474-4422(07)70327-7_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s100489900085","article-title":"Parkinson disease: analysis of mitochondrial DNA in monozygotic twins","volume":"2","author":"Kosel","year":"2000","journal-title":"Neurogenetics"},{"key":"10.1016\/S1474-4422(07)70327-7_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s007020200060","article-title":"Novel mitochondrial DNA mutations in Parkinson's disease","volume":"109","author":"Richter","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/S1474-4422(07)70327-7_bib31","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1006\/bbrc.2002.6388","article-title":"Sequence analysis of the entire mitochondrial genome in Parkinson's disease","volume":"290","author":"Vives-Bauza","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S1474-4422(07)70327-7_bib32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/373937","article-title":"Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease","volume":"72","author":"van der Walt","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.20417","article-title":"Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD","volume":"57","author":"Pyle","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0531-5565(02)00266-8","article-title":"mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish","volume":"38","author":"Ross","year":"2003","journal-title":"Exp Gerontol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib35","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1371\/journal.pgen.0020128","article-title":"Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics","volume":"2","author":"Kazuno","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib36","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ana.410400417","article-title":"Origin and functional consequences of the complex I defect in Parkinson's disease","volume":"40","author":"Swerdlow","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.410440207","article-title":"Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease","volume":"44","author":"Gu","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0","article-title":"A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy","volume":"48","author":"Thyagarajan","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib39","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/1531-8249(200011)48:5<774::AID-ANA11>3.0.CO;2-I","article-title":"An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production","volume":"48","author":"Rana","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbrc.2004.11.093","article-title":"Mitochondrial ND5 mutations in idiopathic Parkinson's disease","volume":"326","author":"Parker","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S1474-4422(07)70327-7_bib41","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1471-4159.2001.00364.x","article-title":"Parkin is associated with cellular vesicles","volume":"78","author":"Kubo","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib43","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z","article-title":"Immunohistochemical and subcellular localization of parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients","volume":"45","author":"Shimura","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib44","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1111\/j.1460-9568.2000.01314.x","article-title":"Parkin expression in the adult mouse brain","volume":"12","author":"Stichel","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/S1474-4422(07)70327-7_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","article-title":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase","volume":"25","author":"Shimura","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib46","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1073\/pnas.240347797","article-title":"Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1","volume":"97","author":"Zhang","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib47","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0092-8674(01)00407-X","article-title":"An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin","volume":"105","author":"Imai","year":"2001","journal-title":"Cell"},{"key":"10.1016\/S1474-4422(07)70327-7_bib48","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1074\/jbc.M407724200","article-title":"Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity","volume":"280","author":"Yamamoto","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib49","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.1093891","article-title":"S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function","volume":"304","author":"Chung","year":"2004","journal-title":"Science"},{"key":"10.1016\/S1474-4422(07)70327-7_bib50","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/hmg\/ddl006","article-title":"Parkin enhances mitochondrial biogenesis in proliferating cells","volume":"15","author":"Kuroda","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib51","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S1474-4422(07)70327-7_bib52","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene","volume":"342","author":"Lucking","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70327-7_bib53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.1132","article-title":"Lewy bodies and parkinsonism in families with parkin mutations","volume":"50","author":"Farrer","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.10613","article-title":"How much phenotypic variation can be attributed to parkin genotype?","volume":"54","author":"Lohmann","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.20587","article-title":"Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers","volume":"58","author":"Pramstaller","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib56","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8","article-title":"An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene","volume":"15","author":"Hayashi","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(07)70327-7_bib57","doi-asserted-by":"crossref","first-page":"43628","DOI":"10.1074\/jbc.M308947200","article-title":"Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons","volume":"278","author":"Goldberg","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib58","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","article-title":"Mitochondrial dysfunction and oxidative damage in parkin-deficient mice","volume":"279","author":"Palacino","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib59","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1471-4159.2006.03777.x","article-title":"Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline","volume":"97","author":"Casarejos","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib60","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1073\/pnas.0737556100","article-title":"Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants","volume":"100","author":"Greene","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib61","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/mds.10695","article-title":"Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations","volume":"19","author":"Muftuoglu","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(07)70327-7_bib62","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/hmg\/ddi377","article-title":"Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism","volume":"14","author":"Silvestri","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib63","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/sj.onc.1204608","article-title":"Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway","volume":"20","author":"Unoki","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/S1474-4422(07)70327-7_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3835(03)00443-9","article-title":"BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential","volume":"201","author":"Nakajima","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/S1474-4422(07)70327-7_bib65","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2006.12.053","article-title":"Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease","volume":"414","author":"Abahuni","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/S1474-4422(07)70327-7_bib66","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/S1474-4422(07)70327-7_bib67","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ana.20256","article-title":"PINK1 mutations are associated with sporadic early-onset parkinsonism","volume":"56","author":"Valente","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib68","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.20251","article-title":"Novel PINK1 mutations in early-onset parkinsonism","volume":"56","author":"Hatano","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib69","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.20247","article-title":"Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism","volume":"56","author":"Rohe","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib70","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1073\/pnas.0500617102","article-title":"Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability","volume":"102","author":"Beilina","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib71","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/brain\/awl114","article-title":"PINK1 protein in normal human brain and Parkinson's disease","volume":"129","author":"Gandhi","year":"2006","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(07)70327-7_bib72","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1471-4159.2006.03845.x","article-title":"Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress","volume":"98","author":"Muqit","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib73","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ana.20206","article-title":"The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism","volume":"56","author":"Healy","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib74","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neulet.2004.09.043","article-title":"Genetic association study of PINK1 coding polymorphisms in Parkinson's disease","volume":"372","author":"Groen","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/S1474-4422(07)70327-7_bib75","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/archneur.63.6.833","article-title":"Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?","volume":"63","author":"Hedrich","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/01.wnl.0000167546.39375.82","article-title":"Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes","volume":"65","author":"Bonifati","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(07)70327-7_bib77","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/archneur.61.12.1898","article-title":"Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease","volume":"61","author":"Rogaeva","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10048-006-0072-y","article-title":"Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis","volume":"8","author":"Grunewald","year":"2007","journal-title":"Neurogenetics"},{"key":"10.1016\/S1474-4422(07)70327-7_bib79","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/mds.20810","article-title":"PINK1 mutations in sporadic early-onset Parkinson's disease","volume":"21","author":"Tan","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(07)70327-7_bib80","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ana.20960","article-title":"A heterozygous effect for PINK1 mutations in Parkinson's disease?","volume":"60","author":"Abou-Sleiman","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib81","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ana.10417","article-title":"Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study","volume":"52","author":"Khan","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib82","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"key":"10.1016\/S1474-4422(07)70327-7_bib83","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"10.1016\/S1474-4422(07)70327-7_bib84","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/hmg\/ddi211","article-title":"Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis","volume":"14","author":"Zhang","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib85","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/bbrc.1997.6132","article-title":"DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras","volume":"231","author":"Nagakubo","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S1474-4422(07)70327-7_bib86","doi-asserted-by":"crossref","first-page":"37556","DOI":"10.1074\/jbc.M101730200","article-title":"DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor","volume":"276","author":"Takahashi","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.embor.7400074","article-title":"DJ-1 has a role in antioxidative stress to prevent cell death","volume":"5","author":"Taira","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/S1474-4422(07)70327-7_bib88","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.1073\/pnas.0402959101","article-title":"The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine\u2013sulfinic acid-driven mitochondrial localization","volume":"101","author":"Canet-Aviles","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib89","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/brain\/awh054","article-title":"The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease","volume":"127","author":"Bandopadhyay","year":"2004","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(07)70327-7_bib90","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bbrc.2003.11.056","article-title":"Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition","volume":"312","author":"Yokota","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S1474-4422(07)70327-7_bib91","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/S1474-4422(07)70327-7_bib92","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/hmg\/ddi134","article-title":"The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis","volume":"14","author":"Xu","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib93","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1371\/journal.pbio.0020362","article-title":"DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation","volume":"2","author":"Shendelman","year":"2004","journal-title":"PLoS Biol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib94","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/hmg\/ddl104","article-title":"Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease","volume":"15","author":"Tang","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib95","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","article-title":"Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1","volume":"45","author":"Goldberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/S1474-4422(07)70327-7_bib96","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nbd.2006.02.001","article-title":"Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+\/K+ ATPase","volume":"23","author":"Pisani","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S1474-4422(07)70327-7_bib97","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib98","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archneur.60.9.1279","article-title":"Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma","volume":"60","author":"Filosto","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib99","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(06)68970-8","article-title":"Mitochondrial disease","volume":"368","author":"Schapira","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","article-title":"Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study","volume":"364","author":"Luoma","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib101","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ana.20831","article-title":"Early-onset familial parkinsonism due to POLG mutations","volume":"59","author":"Davidzon","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib102","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/archneur.61.11.1777","article-title":"A novel polymerase gamma mutation in a family with ophthalmoplegia, neuropathy, and Parkinsonism","volume":"61","author":"Mancuso","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib103","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2004.11.023","article-title":"Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson's disease","volume":"376","author":"Taanman","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/S1474-4422(07)70327-7_bib104","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archneur.64.4.553","article-title":"Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism","volume":"64","author":"Hudson","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib105","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1128\/MCB.24.22.9848-9862.2004","article-title":"Neuroprotective role of the Reaper-related serine protease HtrA2\/Omi revealed by targeted deletion in mice","volume":"24","author":"Martins","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib106","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","article-title":"Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson's disease","volume":"14","author":"Strauss","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib107","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ncb1644","article-title":"The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1","volume":"9","author":"Plun-Favreau","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib108","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nn1443","article-title":"Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease","volume":"8","author":"Chen","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/S1474-4422(07)70327-7_bib109","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"Alpha-synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib110","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/hmg\/9.18.2683","article-title":"Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity","volume":"9","author":"Tabrizi","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib111","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/S1474-4422(07)70327-7_bib112","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neuint.2004.03.029","article-title":"G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage","volume":"45","author":"Orth","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/S1474-4422(07)70327-7_bib113","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53\u2192Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib114","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","article-title":"Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death","volume":"26","author":"Martin","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/S1474-4422(07)70327-7_bib115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.nbd.2005.08.018","article-title":"Mice lacking alpha-synuclein are resistant to mitochondrial toxins","volume":"21","author":"Klivenyi","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S1474-4422(07)70327-7_bib116","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP","volume":"99","author":"Dauer","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib117","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2353\/ajpath.2007.060359","article-title":"Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model","volume":"170","author":"Norris","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib118","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1212\/01.WNL.0000169023.51764.b0","article-title":"LRRK2 mutations in Parkinson disease","volume":"65","author":"Farrer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(07)70327-7_bib119","first-page":"415","article-title":"A common LRRK2 mutation in idiopathic Parkinson's disease","volume":"365","author":"Gilks","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/01.WNL.0000172630.22804.73","article-title":"A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations","volume":"65","author":"Zabetian","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(07)70327-7_bib121","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ana.20510","article-title":"Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation","volume":"57","author":"Deng","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib122","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(05)17829-5","article-title":"A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease","volume":"365","author":"Di Fonzo","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib123","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1086\/429256","article-title":"Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations","volume":"76","author":"Kachergus","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib124","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neulet.2005.07.044","article-title":"The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases","volume":"389","author":"Hernandez","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/S1474-4422(07)70327-7_bib125","first-page":"410","article-title":"Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease","volume":"365","author":"Nichols","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib126","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ana.20456","article-title":"Clinical features of LRRK2-associated Parkinson's disease in central Norway","volume":"57","author":"Aasly","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib127","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.ejhg.5201539","article-title":"Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease","volume":"14","author":"Di Fonzo","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.20791","article-title":"Biochemical and pathological characterization of Lrrk2","volume":"59","author":"Giasson","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddi439","article-title":"The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity","volume":"15","author":"Gloeckner","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(07)70327-7_bib130","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.0508052102","article-title":"Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration","volume":"102","author":"Smith","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib131","doi-asserted-by":"crossref","first-page":"1684247","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(07)70327-7_bib132","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/archneur.63.9.1225","article-title":"The importance of LRRK2 mutations in Parkinson disease","volume":"63","author":"Schapira","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib133","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1042\/bj2350785","article-title":"Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases","volume":"235","author":"Singer","year":"1986","journal-title":"Biochem J"},{"key":"10.1016\/S1474-4422(07)70327-7_bib134","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nm0996-1017","article-title":"Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons","volume":"2","author":"Hantraye","year":"1996","journal-title":"Nature Med"},{"key":"10.1016\/S1474-4422(07)70327-7_bib135","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/S1474-4422(07)70327-7_bib136","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"Hoglinger","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib137","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","article-title":"Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system","volume":"22","author":"Betarbet","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S1474-4422(07)70327-7_bib138","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","article-title":"An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage","volume":"22","author":"Sherer","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/S1474-4422(07)70327-7_bib139","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nbd.2006.02.012","article-title":"Inhibitory effects of pesticides on proteasome activity: implication in Parkinson's disease","volume":"23","author":"Wang","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S1474-4422(07)70327-7_bib140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0006-8993(98)00790-2","article-title":"Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxin","volume":"809","author":"Seaton","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/S1474-4422(07)70327-7_bib141","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1471-4159.2003.02138.x","article-title":"Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe","volume":"88","author":"Champy","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib142","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/qjmed\/86.10.657","article-title":"Smoking and mitochondrial function: a model for environmental toxins","volume":"86","author":"Smith","year":"1993","journal-title":"Q J Med"},{"issue":"suppl 3","key":"10.1016\/S1474-4422(07)70327-7_bib143","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib144","first-page":"451","article-title":"Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function","volume":"183","author":"Thomas","year":"1993","journal-title":"J Anat"},{"key":"10.1016\/S1474-4422(07)70327-7_bib145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2990.1995.tb01022.x","article-title":"Oxidative stress in Parkinson's disease","volume":"21","author":"Schapira","year":"1995","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib146","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson's disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/S1474-4422(07)70327-7_bib147","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson's disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib148","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib149","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.20934","article-title":"Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons","volume":"60","author":"Schapira","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.20932","article-title":"Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats","volume":"60","author":"Zeng","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib151","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.20938","article-title":"Lack of nigrostriatal pathology in a rat model of proteasome inhibition","volume":"60","author":"Manning-Bog","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib152","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.20937","article-title":"Proteasome inhibition and Parkinson's disease modeling","volume":"60","author":"Bove","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib153","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.biochem.68.1.1015","article-title":"The 26S proteasome: a molecular machine designed for controlled proteolysis","volume":"68","author":"Voges","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib154","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1046\/j.1471-4159.2003.01952.x","article-title":"Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease","volume":"86","author":"Hoglinger","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/S1474-4422(07)70327-7_bib155","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib156","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/01.wnl.0000250355.28474.8e","article-title":"A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease","volume":"68","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(07)70327-7_bib157","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","article-title":"Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease","volume":"341","author":"Muller","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/S1474-4422(07)70327-7_bib158","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.64.7.nct60005","article-title":"Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in Parkinson's disease","volume":"64","author":"Storch","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib159","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/exnr.1999.7049","article-title":"Creatine and cyclocreatine attenuate MPTP neurotoxicity","volume":"157","author":"Matthews","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib160","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/01.wnl.0000201252.57661.e1","article-title":"A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease","volume":"66","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(07)70327-7_bib161","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1212\/01.wnl.0000238518.34389.12","article-title":"Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial","volume":"67","author":"Bender","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(07)70327-7_bib162","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1474-4422(06)70602-0","article-title":"TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial","volume":"5","author":"Olanow","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(07)70327-7_bib163","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd2087","article-title":"Novel pharmacological targets for the treatment of Parkinson's disease","volume":"5","author":"Schapira","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S1474-4422(07)70327-7_bib164","doi-asserted-by":"crossref","first-page":"108:3","DOI":"10.1001\/archneur.64.8.1083","article-title":"Treatment options in the modern management of Parkinson disease","volume":"64","author":"Schapira","year":"2007","journal-title":"Arch Neurol"}],"container-title":["The Lancet Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442207703277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442207703277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T08:25:53Z","timestamp":1708590353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442207703277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":164,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1474442207703277"],"URL":"https:\/\/doi.org\/10.1016\/s1474-4422(07)70327-7","relation":{},"ISSN":["1474-4422"],"issn-type":[{"value":"1474-4422","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}